Norges Bank’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-837,417
Closed -$7.08M 1104
2025
Q4
$7.08M Buy
+837,417
New +$5.98M ﹤0.01% 1342
2025
Q3
Sell
-835,874
Closed -$2.89M 1226
2025
Q2
$2.89M Sell
835,874
-3,799,263
-82% -$11.3M ﹤0.01% 1384
2025
Q1
$12.1M Sell
4,635,137
-1,146,741
-20% -$4.49M ﹤0.01% 1258
2024
Q4
$23.8M Sell
5,781,878
-135,637
-2% -$738K ﹤0.01% 1202
2024
Q3
$41.9M Buy
5,917,515
+2,598,173
+78% +$19.4M 0.01% 1034
2024
Q2
$21.6M Sell
3,319,342
-73,283
-2% -$501K ﹤0.01% 1199
2024
Q1
$28.2M Buy
3,392,625
+323,652
+11% +$3.16M ﹤0.01% 1167
2023
Q4
$33.8M Buy
3,068,973
+1,562,145
+104% +$13.2M 0.01% 1087
2023
Q3
$12.7M Sell
1,506,828
-106,956
-7% -$1.15M ﹤0.01% 1383
2023
Q2
$20.3M Hold
1,613,784
﹤0.01% 1250
2023
Q1
$26.6M Sell
1,613,784
-174,539
-10% -$3.13M 0.01% 1137
2022
Q4
$26.7M Buy
1,788,323
+57,636
+3% +$1.1M 0.01% 1130
2022
Q3
$38.7M Buy
1,730,687
+313,499
+22% +$6.88M 0.01% 880
2022
Q2
$23.7M Buy
1,417,188
+479,262
+51% +$10.3M 0.01% 1159
2022
Q1
$28.1M Buy
937,926
+117,926
+14% +$2.86M 0.01% 1206
2021
Q4
$25.2M Buy
820,000
+322,235
+65% +$10.2M 0.01% 1347
2021
Q3
$15.7M Buy
497,765
+267,135
+116% +$8.99M ﹤0.01% 1609
2021
Q2
$8.44M Buy
230,630
+24,234
+12% +$799K ﹤0.01% 1816
2021
Q1
$7.13M Sell
206,396
-2,689
-1% -$117K ﹤0.01% 1864
2020
Q4
$8.69M Buy
+209,085
New +$9.45M ﹤0.01% 1792

Other funds holding RLAY